Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotics
Fierce Pharma
Iterum initiates wind-down after failure to offload antibiotic
Iterum engaged with two potential suitors for its approved antibiotic Orlynvah, but a deal ultimately couldn't be struck.
Darren Incorvaia
Mar 31, 2026 2:06pm
Former Spero execs fined by SEC over antibiotic efficacy claims
Jan 20, 2026 11:34am
Fierce's favorite research stories of 2025
Dec 23, 2025 5:00am
GSK unveils pivotal data on oral antibiotic ahead of FDA filing
Oct 21, 2025 10:55am
Generative AI models build new antibiotics from scratch
Aug 14, 2025 11:00am
Basilea secures $39M as part of BARDA antifungal funding plan
Jul 8, 2025 3:52am